Tag: Bio

Latest News

IVERIC bio to Announce Zimura® 18 Month Data from the OPH2003 Phase 3 Clinical Trial in Geographic Atrophy Secondary to Age-Related Macular Degeneration and Host Conference Call on Monday, June 15, 2020

Newsemia
NEW YORK–(BUSINESS WIRE)–IVERIC announced that it will report 18 month data from the Zimura® Phase 3 clinical trial in geographic atrophy secondary to AMD on...
Latest News

Global Quercetin Market Insights to 2025 – Featuring Hawk Bio-Engineering, Aktin Chem & Sanjiang Bio Among Others – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Quercetin Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Application” report has been added to...
Latest News

Aurora Bio, Inc Announces Clinical Data on Lead Program, AUR01, a Novel Systemic Amyloidosis Imaging Tracer, at the Upcoming 61st American Society of Hematology Annual Meeting and Exposition

Newsemia
ORLANDO, Fla.–(BUSINESS WIRE)–Aurora Bio, Inc www.Aurorabioinc.com today announced data for the company’s novel PET radiotracer, AUR01, in development for systemic amyloidosis, was presented by Dr....
Latest News

GVK BIO annonce la promotion de Sudhir Kumar Singh au poste de directeur des opérations et la nomination de Ramesh Subramanian en tant que nouveau directeur commercial de GVK BIO

Newsemia
HYDERABAD, Inde–(BUSINESS WIRE)–GVK BIO, une importante organisation de recherche et développement sous contrat (Contract Research and Development Organisation, CRDO), a le plaisir d’annoncer la promotion...
Latest News

CORRECTING and REPLACING Civilization Ventures Announces Portfolio Exit with Acquisition of Singular Bio by Invitae (NYSE: NVTA)

Newsemia
SAN FRANCISCO–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24NVTA&src=ctag" target="_blank">$NVTA</a> <a href="https://twitter.com/hashtag/diagnostics?src=hash" target="_blank">#diagnostics</a>–In the headline, and in the first sentence of the release, “(NASDAQ: NVTA)” should instead read “(NYSE: NVTA)”...
Biology

IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases

Newsemia
NEW YORK and SOMERSET, N.J. (PRWEB) June 17, 2019 IVERIC bio, Inc. (NASDAQ: ISEE) and Catalent Biologics, today announced that they have entered into an...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World